Dr. D. Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune, was established in the year 1996 with a divine mission and cherished desire of our Chancellor Hon’bleDr.P.D. Patilwith the blessings of Honorable Dr. D. Y. Patil, Founder President. The institute is further nurtured and progressed under the dynamic leadership of ProChancellor, Dr. D.Y. Patil Vidyapeeth Hon’ble(Mrs) Dr. Bhagyashree Patil.

The Vision and Mission of establishing the College, Hospital and Research Centre is making healthcare easily accessible to all.

 Since its inception, the Medical College, Hospital & Research Centre has made its mark as an “Institute of Excellence”. Today, it is recognized as a Renowned Teaching and Research Institution in the Country. It has received recognition from the National Medical Commission, New Delhi. The Institute initially started with MBBS Programme (UG) with an intake of 100 seats. It has expanded further with 250 MBBS seats, 220 MD & MS (PG) seats, 30 M.Ch / D.M (Superspeciality) seats, MPH programme in one subject, Msc Programme in 4 subjects, FellowshipCourses in 24 subjects, PhD Courses in all medical subjects, Certificate Courses in 8 subjects and Short TermTraining Programmes (STTP) in 12 subjects within a short span of 27 years.

Following are the Achievements and Rankings of the College:

  • The Institute is recognized by the National Medical Commission (Erstwhile Medical Council of India), New Delhi, and the Ministry of Health and Family Welfare, of India, New Delhi for conducting Undergraduate, Postgraduate, and Superspeciality programs. 
  • D. Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune being a constituent unit of Dr. D. Y. Patil Vidyapeeth, Pimpri, Pune has been accorded the status of “University” under Section 3 of the UGC Act, 1956.
  • The Institute is accredited (3rd cycle) by NAAC with a CGPA of 3.64 on a four-point scale at “A++” Grade and it is ISO 9001: 2015 certified Deemed to be University.
  • The Institute was ranked 11th in the medical category in the NIRF Ranking 2024.
  • In recognition of being a “Safe and Secure Educational Facility”, it was honoured with the Finest India Skills & Talent Award in 2023.
  • As part of the Global Recognition Program, the Institution was conferred with the prestigious “IBCLC Hospital-based Care Award 2023.”
  • The peer-reviewed journalnamely, “The Medical Journal of Dr. D. Y. Patil Vidyapeeth” was included in Scopus and in the list of UGC Care journals for giving academic credits to the faculty.
  • Designated as “ICMR Regional Clinical Trial Unit”.
  • Also designated by ICMR for the SARS-CoV-2 Omicron Kit Evaluation Program.
  • State-of-the-Art NABL-accredited Central Clinical Laboratory Facility for various investigations under Pathology, Biochemistry, and Microbiology.
  • Highly qualified, proficient, and committed faculty who are the backbone of the Institute involved in the teaching-learning process to achieve academic excellence with Man-Machine Interaction.
  • Central Library with excellent infrastructure and a stack section of more than 35,206 medical books and 266 International and National journals.
  • Spacious, air-conditioned, ICT enabledLecture Halls and Seminar Hallswith high-speed internet & Wi-Fi facilities. 
  • World-class Hostel Facilities available for boys and girls in the campus.
  • Excellent Clinical Skills and Simulation Laboratory with latest mannequins and equipment.
  • State-of-the-Art and highly sophisticated Genetics and Molecular Diagnostics Laboratories.
  • The Institute has collaborations with International Academic Institutes &Organizations Johns Hopkins University USA, Boston University USA and MRI Global, USA for research. The Institute served as a COVID-19 International study site solidarity trial for WHO X & the Recovery Trial of the University of Oxford UK.Harvard Medical School and Centre for Global Health Delivery Dubai, for Research and Education.
  • National collaborations with Council for Scientific and Industrial Research (CSIR), Indian Council for Medical Research (ICMR), Scientific and Research Organisation (SIRO), Revised Tuberculosis Control Programme, CARE India etc. Our institute is an ICMR West Zone site for the Indian Clinical Trial and Education Network (INTENT)
  • The Institute is actively involved in Clinical Research supported by the Serum Institute of India Pvt. Ltd, Genova Biopharmaceutical Ltd, Reliance Life Sciences Pvt. Ltd., Intas Pharmaceuticals Ltd, Lupin Pharmaceuticals Pvt. Ltd., Translumina Therapeutics LLP, Sun Pharma, Panacea Biotec Ltd, Johnson & Johnson, GSK India Pharma etc.
  • Also coordinate with Clinical Research Organizations (CROs) like PPD, Diagnosearch, JSS, Clinical Research Network India (CRNI), Bio Agile Therapeutics Pvt. Ltd. etc. for clinical research.
  • The Faculty Members are involved in Research and have published Research Papers in National and International Journals such as: Cell Metabolism, Lancet, etc. with the Highest Impact Factor.
  • The Faculty undertake Research Projects approved and funded by the Indian Council for Medical Research (ICMR), DST (Department of Science and Technology), DBT (Department of Biotechnology) and Dr. D. Y. Patil Vidyapeeth, Pune.
  • The Faculty also undertakes Consultancy Projects like Five-Armed Polio Study, Phase II/III dengue vaccine, Phase III Hexavalent vaccine, Phase I Measles, Indian EPI Polio Vaccine (WHO) and Evaluation of research projects.
  • 26 Clinical Trials have been completed.
  • 6 Patents and 5 Copyrights have been published.
  • Academic Results of students are the best in the University as many University rankers are being produced by the Institute.
  • To accomplish Holistic Development of the students, the Institute has a strong mentorship system and also various student chapters of professional organizations.
  • Established MOUs with Prestigious International and National Organizations.
  • The Institute has well-maintained lawns, trees and various plantations with medicinal properties leading to a Healthy and GreenEnvironment.
  • Global-level Video Conferencing with Johns Hopkins University, USA conducted monthly.
  • Future plans are to start Super specialization in Radiation Oncology, Endocrinology, Neonatology, Cardiac Anaesthesia, etc. In addition, Bone Marrow Transplant and Therapeutic OncologyServices are being planned.